These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8309186)

  • 1. [A trial of the clinical use of the Russian hypocholesterolemic preparation fenbutol--an analog of probucol].
    Nechaev AS; Gerasimenko TI; Gratsianskiĭ NA; Nikitina NA; Kliuchnikova ZhI
    Kardiologiia; 1993; 33(7):7-10, 3. PubMed ID: 8309186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of long-term fenbutol therapy on lipid metabolism in patients with ischemic heart disease].
    Lupanov VP; Liakishev AA; Tvorogova MG; Titov VN; Kukharchuk VV
    Kardiologiia; 1993; 33(4):19-22. PubMed ID: 7933784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
    Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
    Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probucol on serum lipoprotein and apoprotein profiles in renal transplant patients.
    Okubo M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Kumano K; Endo T
    Am J Kidney Dis; 1998 Feb; 31(2):356-9. PubMed ID: 9469511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probucol on hyperlipidemic patients with cardiac allografts.
    Anderson JL; Schroeder JS
    J Cardiovasc Pharmacol; 1979; 1(3):353-65. PubMed ID: 94402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM; Vega GL; Yuan Z; Battisti WP; Brady WE; Palmisano J
    Am J Cardiol; 2005 Feb; 95(4):462-8. PubMed ID: 15695129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.
    Lane JT; Subbaiah PV; Otto ME; Bagdade JD
    J Lab Clin Med; 1991 Aug; 118(2):120-8. PubMed ID: 1856575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term effects of probucol on serum lipid levels.
    McCaughan D
    Arch Intern Med; 1981 Oct; 141(11):1428-32. PubMed ID: 7025778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of blood antioxidative enzyme activity and lipid levels in patients with coronary atherosclerosis treated with probucol].
    Revenko VM; Lupanov VP; Lankin VZ; Tikhaze AK; Liakishev AA; Kukharchuk VV
    Kardiologiia; 1991 Oct; 31(10):41-4. PubMed ID: 1753580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
    Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA; Gorin VV; Shingireĭ MV; Kliuchnikova ZhI; Diukov IV
    Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.
    ter Avest E; Abbink EJ; de Graaf J; Tack CJ; Stalenhoef AF
    Eur J Clin Invest; 2005 Sep; 35(9):558-64. PubMed ID: 16128862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B
    J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.